Albert G. White III Sells 114,992 Shares of The Cooper Companies, Inc. (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cooper Companies Stock Performance

Shares of COO traded down $0.61 during mid-day trading on Friday, hitting $110.49. The stock had a trading volume of 1,914,533 shares, compared to its average volume of 1,125,396. The firm has a market cap of $22.00 billion, a P/E ratio of 64.79, a PEG ratio of 2.60 and a beta of 0.98. The business has a fifty day moving average price of $97.54 and a 200-day moving average price of $95.48. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business’s revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.84 earnings per share. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

Analyst Upgrades and Downgrades

COO has been the subject of several analyst reports. Wells Fargo & Company increased their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Stifel Nicolaus reissued a “buy” rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Robert W. Baird increased their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Finally, Piper Sandler increased their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $115.00.

Institutional Trading of Cooper Companies

Several hedge funds have recently made changes to their positions in the company. Sanctuary Advisors LLC purchased a new position in shares of Cooper Companies in the second quarter valued at $3,043,000. Cetera Investment Advisers grew its position in shares of Cooper Companies by 6.3% in the second quarter. Cetera Investment Advisers now owns 22,244 shares of the medical device company’s stock valued at $1,942,000 after purchasing an additional 1,309 shares in the last quarter. B. Riley Wealth Advisors Inc. grew its position in shares of Cooper Companies by 113.1% in the second quarter. B. Riley Wealth Advisors Inc. now owns 2,529 shares of the medical device company’s stock valued at $221,000 after purchasing an additional 1,342 shares in the last quarter. Quarry LP grew its position in shares of Cooper Companies by 1,225.9% in the second quarter. Quarry LP now owns 2,718 shares of the medical device company’s stock valued at $237,000 after purchasing an additional 2,513 shares in the last quarter. Finally, Wallace Advisory Group LLC purchased a new position in shares of Cooper Companies in the second quarter valued at $290,000. 24.39% of the stock is currently owned by institutional investors.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.